【ChiCTR2600130030】Cryotherapy Versus Lidocaine Spray for the Management of Chemotherapy-Induced Oral Mucositis: A Randomized Controlled Trial
ChiCTR2600130030
尚未开始
/
/
/
2026-08-13
/
/
cancer
Cryotherapy Versus Lidocaine Spray for the Management of Chemotherapy-Induced Oral Mucositis: A Randomized Controlled Trial
Cryotherapy Versus Lidocaine Spray for the Management of Chemotherapy-Induced Oral Mucositis: A Randomized Controlled Trial
41001
Primary: Compare oral cryotherapy and topical lidocaine spray in reducing oral mucositis severity. Secondary: Compare oral pain intensity, time to recovery, patient tolerance, and adverse events.
随机平行对照
其它
The random allocation sequence was generated by an independent researcher who was not involved in participant recruitment, intervention delivery, or outcome assessment. A computer-generated random number sequence with a 1:1 allocation ratio was used to assign participants to either the oral cryotherapy group or the topical lidocaine spray group.
None
self-raised
/
30
/
2026-10-20
2026-12-15
/
Adults ≥18 years; diagnosed with cancer; receiving chemotherapy; developed chemotherapy-induced oral mucositis; able to provide informed consent. Adults ≥18 years; diagnosed with cancer; receiving chemotherapy; developed chemotherapy-induced oral mucositis; able to provide informed consent.；
请登录查看Mucositis from causes other than chemotherapy; concurrent head and neck radiotherapy; allergy to lidocaine; contraindication to cryotherapy; severe cognitive impairment; refusal to participate.；
请登录查看College of Nursing, University of Baghdad
/
College of Nursing, University of Baghdad的其他临床试验
- Effect of Aloe Vera- Peppermint compound gel in prevention bed injuries among ICU bedridden patients
- Cryotherapy Versus Lidocaine Spray for the Management of Chemotherapy-Induced Oral Mucositis: A Randomized Controlled Trial
- Protective Dressing on Reducing Nasal Injury in Preterm Infants treating with CPAP
- Effect of a Health Education Program on Lung Cancer Screening among College Students Who Smoke
- Effect of Buteyko Breathing Exercises and Virtual Reality on Anxiety and sleep Quality in Patients poste Coronary Artery Bypass Grafting: A Randomized Controlled Trial
- Effect of Combined Stress Ball and Lavender Oil on Pain and Anxiety during Arteriovenous Cannulation in Hemodialysis Patients: A Randomized Controlled Trial
College of Nursing, University of Baghdad的其他临床试验
- Effect of Aloe Vera- Peppermint compound gel in prevention bed injuries among ICU bedridden patients
- Cryotherapy Versus Lidocaine Spray for the Management of Chemotherapy-Induced Oral Mucositis: A Randomized Controlled Trial
- Protective Dressing on Reducing Nasal Injury in Preterm Infants treating with CPAP
- Effect of a Health Education Program on Lung Cancer Screening among College Students Who Smoke
- Effect of Buteyko Breathing Exercises and Virtual Reality on Anxiety and sleep Quality in Patients poste Coronary Artery Bypass Grafting: A Randomized Controlled Trial
- Effect of Combined Stress Ball and Lavender Oil on Pain and Anxiety during Arteriovenous Cannulation in Hemodialysis Patients: A Randomized Controlled Trial
- Effect of Listening to Quran versus Verbal Communication on Respiratory Suctioning-Induced Pain and Agitation among Intubated Patients: A Randomized Controlled Trail
最新临床资讯
-
飞眸医疗首例人体临床试验（FIH）成功开展，国产飞秒屈光设备竞逐540亿屈光市场
动脉网-最新2026-09-10
-
和铂医药：超长效靶向TSLP抗体哮喘二期临床取得阳性结果，三期临床已启动
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
动脉网-最新2026-09-09
-
药明康德2026-09-09
-
一度医药2026-09-08
-
阿斯利康中国2026-09-08
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-09-26
-
2026-09-26
-
2026-09-26
-
摩熵咨询 20 8
-
摩熵咨询 20 11
-
摩熵咨询 34 56
-
颁布机构：国家药品监督管理局 2026-09-10
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-09-28
-
2026-09-26
-
2026-09-26
-
摩熵咨询 35 71
-
摩熵咨询 28 60
-
摩熵咨询 34 42
-
颁布机构：国家市场监督管理总局 2026-09-18
-
颁布机构：国家市场监督管理总局 2026-09-17
-
颁布机构：国家市场监督管理总局 2026-08-10